No Data
Shandong Sinobioway Biomedicine (002581.SZ) plans to launch a stock options incentive plan for 2024, with an exercise price of 12.35 yuan per share.
Shandong sinobioway biomedicine (002581.SZ) announced the 2024 stock options incentive plan (draft), which grants...
Express News | Shandong Sinobioway Biomedicine plans to transfer 26.84% of its equity in subsidiary Yingkou Chemical for 74.0254 million yuan.
Unnamed Pharmaceuticals: Report for the third quarter of 2024
Shandong Sinobioway Biomedicine (002581.SZ): net income for the first three quarters was 14.6263 million yuan, a year-on-year decrease of 50.78%.
Greenway Vision October 29th | Shandong Sinobioway Biomedicine (002581.SZ) announced its third quarter report for 2024, achieving revenue of 0.315 billion yuan in the first three quarters, a decrease of 6.99% year-on-year; net income attributable to shareholders of listed companies was 14.6263 million yuan, a decrease of 50.78% year-on-year; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 16.5706 million yuan, a decrease of 49.02% year-on-year; basic earnings per share was 0.0222 yuan.
Unnamed Pharmaceuticals: 2024 Semi-Annual Report Summary
Unnamed Pharmaceuticals: Semi-Annual Report 2024
No Data
No Data